Comparative Pharmacology
Head-to-head clinical analysis: DISPERMOX versus DYCILL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DISPERMOX versus DYCILL.
DISPERMOX vs DYCILL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity and disrupting peptidoglycan cross-linking.
Penicillin G benzathine is a slow-release parenteral formulation of penicillin G that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidation, and activating autolytic enzymes.
Adults: 1 g (as amoxicillin 875 mg + clavulanate 125 mg) orally every 12 hours for 7-10 days.
250 mg orally every 6 hours or 500 mg orally every 12 hours.
None Documented
None Documented
Terminal elimination half-life 1.5 hours; prolonged in renal impairment.
0.5-1 hour; prolonged in renal impairment (up to 20 hours in severe cases).
Renal excretion 80% as unchanged drug, biliary/fecal 10%.
Renal: approx. 60-80% unchanged by glomerular filtration and tubular secretion. Biliary/fecal: minor (less than 10%).
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic